Trademark
Full logoAbout Moderna
Moderna is a biotechnology company built around mRNA medicine, best known for Spikevax — its COVID-19 vaccine that was one of the first two mRNA vaccines authorized for human use (alongside Pfizer-BioNTech's Comirnaty). Founded in 2010 and headquartered in Cambridge, Massachusetts, the company is developing mRNA vaccines for RSV (mRESVIA), CMV, influenza, and combination flu+COVID, plus a personalized cancer vaccine in partnership with Merck. Moderna's mRNA platform also targets rare disease and autoimmune conditions. The company is in the middle of a multi-year cost-reduction program after the post-COVID revenue cliff.
About the Moderna logo
The Moderna (MRNA) logo is part of the Tickericons pack — a hand-crafted set of logos for every company in the S&P 500. Each logo is manually redrawn to a consistent grid, weight, and corner radius so MRNA sits cleanly next to other tickers in cap tables, dashboards, equity research, and fintech UI.
You get two styles: the trademark (just the symbol, ideal for grids and tight UI) and the full logo (mark plus wordmark, ideal when there's room to breathe). Both ship as scalable SVG, high-resolution PNG, and reusable Figma components.
Moderna was added to the S&P 500 on Jul 21, 2021 and is currently classified under the Health Care sector.
Index history
Jul 21, 2021 · Added to the S&P 500
AstraZeneca acquired Alexion Pharmaceuticals.
Other Health Care companies
See all →
abtAbbott LaboratoriesMar 4, 195725,279
abbvAbbVieDec 31, 20124,888
aAgilent TechnologiesJun 5, 20009,480
algnAlign TechnologyJun 19, 20173,257
amgnAmgenJan 2, 199212,557
baxBaxter InternationalSep 30, 197219,590
bdxBecton Dickinson and CoSep 30, 197219,590
techBio-Techne CorporationAug 30, 20211,724
biibBiogenNov 13, 20038,224
bsxBoston Scientific CorporationFeb 24, 199511,408
Get all S&P 500 logos
One-time payment. SVG, PNG, and a Figma library. Free updates as the index changes.